Viewing Study NCT00279435


Ignite Creation Date: 2025-12-24 @ 10:13 PM
Ignite Modification Date: 2025-12-25 @ 7:48 PM
Study NCT ID: NCT00279435
Status: TERMINATED
Last Update Posted: 2012-03-12
First Post: 2006-01-17
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Visilizumab Versus Placebo in Subjects With Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study
Sponsor: Facet Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module